loading
Schlusskurs vom Vortag:
$21.81
Offen:
$22.15
24-Stunden-Volumen:
1.10M
Relative Volume:
0.93
Marktkapitalisierung:
$1.93B
Einnahmen:
$23.38M
Nettoeinkommen (Verlust:
$-155.22M
KGV:
-10.05
EPS:
-2.19
Netto-Cashflow:
$-134.36M
1W Leistung:
+2.75%
1M Leistung:
+1.62%
6M Leistung:
-4.84%
1J Leistung:
-48.48%
1-Tages-Spanne:
Value
$21.50
$22.38
1-Wochen-Bereich:
Value
$21.33
$22.81
52-Wochen-Spanne:
Value
$13.45
$44.42

Ideaya Biosciences Inc Stock (IDYA) Company Profile

Name
Firmenname
Ideaya Biosciences Inc
Name
Telefon
650-443-6209
Name
Adresse
5000 SHORELINE CT, SUITE 300, SOUTH SAN FRANCISCO, CA
Name
Mitarbeiter
131
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-05
Name
Neueste SEC-Einreichungen
Name
IDYA's Discussions on Twitter

Vergleichen Sie IDYA mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
IDYA
Ideaya Biosciences Inc
22.02 1.88B 23.38M -155.22M -134.36M -2.19
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
470.13 119.21B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
560.93 59.16B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.28 40.57B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
571.23 34.02B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
295.59 29.19B 3.81B -644.79M -669.77M -6.24

Ideaya Biosciences Inc Stock (IDYA) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-07-22 Eingeleitet TD Cowen Buy
2025-07-10 Fortgesetzt Goldman Neutral
2025-06-26 Eingeleitet Wells Fargo Overweight
2024-11-18 Eingeleitet Stephens Overweight
2024-11-05 Herabstufung Leerink Partners Outperform → Market Perform
2024-10-24 Eingeleitet UBS Buy
2024-10-15 Eingeleitet Cantor Fitzgerald Overweight
2024-07-08 Eingeleitet Mizuho Outperform
2024-03-08 Eingeleitet BTIG Research Buy
2023-08-08 Eingeleitet SVB Securities Outperform
2023-05-24 Eingeleitet Goldman Buy
2023-04-24 Hochstufung Stifel Hold → Buy
2023-03-23 Eingeleitet Berenberg Buy
2023-02-28 Eingeleitet RBC Capital Mkts Outperform
2022-12-28 Eingeleitet CapitalOne Overweight
2022-10-27 Eingeleitet Citigroup Buy
2022-08-15 Herabstufung Stifel Buy → Hold
2022-07-18 Fortgesetzt Oppenheimer Outperform
2022-03-10 Hochstufung Stifel Hold → Buy
2021-09-23 Eingeleitet Stifel Hold
2021-06-04 Fortgesetzt Robert W. Baird Outperform
2021-03-11 Eingeleitet Guggenheim Buy
2020-10-07 Eingeleitet Wedbush Outperform
2020-09-01 Eingeleitet Northland Capital Outperform
2020-07-13 Hochstufung JP Morgan Neutral → Overweight
2020-06-17 Bestätigt H.C. Wainwright Buy
2020-04-06 Eingeleitet H.C. Wainwright Buy
2020-03-13 Eingeleitet ROTH Capital Buy
2019-10-17 Eingeleitet Oppenheimer Outperform
2019-09-10 Eingeleitet Robert W. Baird Outperform
2019-06-17 Eingeleitet Citigroup Buy
2019-06-17 Eingeleitet JP Morgan Neutral
2019-06-17 Eingeleitet Jefferies Buy
Alle ansehen

Ideaya Biosciences Inc Aktie (IDYA) Neueste Nachrichten

pulisher
01:17 AM

IDEAYA Biosciences Inc. Stock Analysis and ForecastHigh-margin investment plays - jammulinksnews.com

01:17 AM
pulisher
Jul 22, 2025

Is IDEAYA Biosciences Inc. a good long term investmentRobust financial gains - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What drives IDEAYA Biosciences Inc. stock priceOver 200% growth - Autocar Professional

Jul 22, 2025
pulisher
Jul 22, 2025

Breakthrough Lung Cancer Drug IDE849 Shows First Human Results: 70+ Patient Data Coming at WCLC 2025 - Stock Titan

Jul 22, 2025
pulisher
Jul 22, 2025

Melanoma Market Anticipates a Dynamic Shift During the Forecast Period (2025–2034) Owing to the Strong Pipeline Activity | DelveInsight - GlobeNewswire Inc.

Jul 22, 2025
pulisher
Jul 22, 2025

What analysts say about IDEAYA Biosciences Inc. stockHigh-return market picks - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

IDEAYA Biosciences: TD Cowen initiates coverage with Buy rating. - AInvest

Jul 22, 2025
pulisher
Jul 22, 2025

Promising Pipeline and Strategic Focus Drive Buy Rating for IDEAYA Biosciences - TipRanks

Jul 22, 2025
pulisher
Jul 22, 2025

TD Cowen initiates Ideaya Biosciences stock with Buy rating By Investing.com - Investing.com Canada

Jul 22, 2025
pulisher
Jul 21, 2025

autocarpro> 2025> What analysts say about IDEAYA Biosciences Inc. stockPhenomenal trading returns - Autocar Professional

Jul 21, 2025
pulisher
Jul 21, 2025

IDEAYA Biosciences CEO Fireside Chat: Precision Medicine Updates at BTIG Conference - Stock Titan

Jul 21, 2025
pulisher
Jul 16, 2025

(IDYA) Proactive Strategies - news.stocktradersdaily.com

Jul 16, 2025
pulisher
Jul 15, 2025

Why IDEAYA Biosciences Inc. stock attracts strong analyst attentionROI Driven Alerts - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How IDEAYA Biosciences Inc. stock performs during market volatilityDaily Stock Radar - Newser

Jul 15, 2025
pulisher
Jul 11, 2025

Ideaya Biosciences stock gets Neutral rating from Goldman Sachs By Investing.com - Investing.com Canada

Jul 11, 2025
pulisher
Jul 10, 2025

Ideaya Biosciences price target lowered to $30 from $57 at RBC Capital - MSN

Jul 10, 2025
pulisher
Jul 10, 2025

Ideaya Biosciences shares fall 2.68% intraday as Biocytogen Pharmaceuticals enters into a global licensing agreement with BeOne Medicines. - AInvest

Jul 10, 2025
pulisher
Jul 10, 2025

RBC Capital Initiates IDEAYA Biosciences(IDYA.US) With Buy Rating, Announces Target Price $30 - 富途牛牛

Jul 10, 2025
pulisher
Jul 09, 2025

Ideaya Biosciences stock price target lowered to $30 by RBC Capital - Investing.com Canada

Jul 09, 2025
pulisher
Jul 09, 2025

RBC Cuts Price Target on IDEAYA Biosciences to $30 From $57, Keeps Outperform, Speculative Risk - MarketScreener

Jul 09, 2025
pulisher
Jul 07, 2025

Here's Why We're Watching IDEAYA Biosciences' (NASDAQ:IDYA) Cash Burn Situation - 富途牛牛

Jul 07, 2025
pulisher
Jul 06, 2025

(IDYA) Long Term Investment Analysis - news.stocktradersdaily.com

Jul 06, 2025
pulisher
Jun 30, 2025

IDEAYA Biosciences, Inc.(NasdaqGS:IDYA) dropped from Russell Small Cap Comp Growth Index - MarketScreener

Jun 30, 2025
pulisher
Jun 30, 2025

IDEAYA Biosciences: A Precision Oncology Play Gains Momentum with Russell 2000 Inclusion - AInvest

Jun 30, 2025
pulisher
Jun 29, 2025

Why IDEAYA's Russell Exit Could Be a Biotech Contrarian's Dream - AInvest

Jun 29, 2025
pulisher
Jun 28, 2025

IDEAYA Biosciences: A CFO's Deal-Making Expertise Could Be the Catalyst for a Breakout Year - AInvest

Jun 28, 2025
pulisher
Jun 27, 2025

IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - PR Newswire

Jun 27, 2025
pulisher
Jun 26, 2025

This NRG Energy Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday - Benzinga

Jun 26, 2025
pulisher
Jun 24, 2025

Ideaya Biosciences shareholders elect directors and approve auditor at annual meeting - Investing.com

Jun 24, 2025
pulisher
Jun 17, 2025

Rhumbline Advisers Increases Stock Holdings in IDEAYA Biosciences, Inc. (NASDAQ:IDYA) - Defense World

Jun 17, 2025
pulisher
Jun 16, 2025

IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Holdings Lifted by GAMMA Investing LLC - Defense World

Jun 16, 2025
pulisher
Jun 16, 2025

Handelsbanken Fonder AB Raises Stock Position in IDEAYA Biosciences, Inc. (NASDAQ:IDYA) - Defense World

Jun 16, 2025
pulisher
Jun 16, 2025

IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Receives Average Recommendation of “Moderate Buy” from Brokerages - Defense World

Jun 16, 2025
pulisher
Jun 11, 2025

Cantor Fitzgerald Comments on IDYA FY2026 Earnings - Defense World

Jun 11, 2025
pulisher
Jun 09, 2025

Transcript : IDEAYA Biosciences, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-09-2025 10 - MarketScreener

Jun 09, 2025
pulisher
Jun 08, 2025

IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Shares Purchased by California State Teachers Retirement System - Defense World

Jun 08, 2025
pulisher
Jun 02, 2025

IDEAYA Biosciences to Participate in Upcoming June 2025 Investor Relations Events - PR Newswire

Jun 02, 2025

Finanzdaten der Ideaya Biosciences Inc-Aktie (IDYA)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$21.80
price up icon 0.51%
$36.10
price up icon 1.26%
$102.92
price up icon 0.14%
$26.54
price up icon 0.76%
$111.44
price up icon 2.32%
biotechnology ONC
$295.59
price up icon 1.25%
Kapitalisierung:     |  Volumen (24h):